Photo from Reuben Ben-David/X
May 13, 2024, 09:47
Reuben Ben-David: Gem/Doce is gaining grounds in the treatment of NMIBC
Reuben Ben-David, Society of Urological Oncology (SUO) fellow at the Mount Sinai Hospital NYC, shared on X:
“Excited about our latest publication! Gem/Doce induction plus maintenance is superior to induction only.
The use of 2 grams of gemcitabine improved all grades of recurrence but didn’t decrease high-grade recurrences over 1 gram of gemcitabine.
Gem/Doce is gaining grounds in the treatment of NMIBC.” .
Source: Reuben Ben-David/X